NCT06118385View on ClinicalTrials.gov

Study Investigating the Safety, Tolerability, PK and Food Effect of BEN8744.

PHASE1CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

August 30, 2023

Primary Completion Date

March 14, 2024

Study Completion Date

March 18, 2024

Conditions
Healthy Volunteer Study
Interventions
DRUG

BEN8744

Formulated powder in capsule for oral administration. Supplied as filled Size 0 Swedish Orange capsule. Doses: 2mg, 10mg and 40mg.

DRUG

Matching Placebo

Formulated powder in capsule for oral administration. Supplied as filled Size 0 Swedish Orange capsule. Doses: 2mg, 10mg and 40mg.

Trial Locations (1)

Unknown

Hammersmith Medicines Research, London

Sponsors

Lead Sponsor

BenevolentAI Bio
All Listed Sponsors
lead

BenevolentAI Bio

INDUSTRY

NCT06118385 - Study Investigating the Safety, Tolerability, PK and Food Effect of BEN8744. | Biotech Hunter | Biotech Hunter